K-Dur Doesn't Apply To Authorized Generic Deals, Judge Says
By Melissa Lipman ( December 6, 2012, 8:52 PM EST) -- A New Jersey judge dismissed a putative class action against GlaxoSmithKline PLC and Teva Pharmaceutical Industries Ltd. on Thursday, ruling that the Third Circuit's recent decision subjecting so-called pay-for-delay pharmaceutical patent settlements to tougher antitrust scrutiny only applied to deals including cash payments....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.